Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x100px

Person › Details

Marc Gitzinger (BioVersys AG)

Gitzinger, Marc (BioVersys 2008– CEO + Co-founder)

	Organisation	BioVersys AG
	Product	antibiotic
	Product 2	TRIC (Transcriptional Repressor Inhibiting Compound)

Record changed: 2024-05-07

Picture Berlin Partner Top News CareSyntax Raises $61m for Bio Cheese 650x200px

More documents for Marc Gitzinger

[1] BioVersys AG. (5/7/24). "Press Release: BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million". Basel....
[2] BioVersys AG. (1/5/23). "Press Release: BioVersys Extends Its Series C Round to CHF 32.6 Million with investment from the AMR Action Fund". Basel....
[3] BioVersys AG. (6/8/22). "Press Release: BioVersys AG Announces Successful First Closing of CHF 24.2 Million Series C Financing to Develop Clinical Pipeline of Novel AMR Therapies". Basel....
[4] BioVersys AG. (6/1/21). "Press Release: BioVersys Receives a Second CARB-X Award of up to US$ 15.34 Milllion for BV300". Basel....
[5] BioVersys AG. (5/18/21). "Press Release: Martin Bott Appointed CFO of BioVersys". Basel....
[6] BioVersys AG. (4/14/21). "Press Release: BioVersys Receives €20 Million in EU financing to Support Development of New Antibiotics"....
[7] BioVersys AG. (9/1/20). "Press Release: BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)